Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoporosis: taking a fresh look

U S Barzel1

  • 1Albert Einstein College of Medicine, Bronx, New York, USA.

Hospital Practice (1995)
|May 15, 1996
PubMed
Summary
This summary is machine-generated.

Researchers are refining risk factors for bone density loss and improving early detection methods. Promising strategies to inhibit bone loss and promote bone formation include alendronate and slow-release fluoride.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case 9-1999: Wegener's granulomatosis.

The New England journal of medicine·1999
Same author

Excess dietary protein can adversely affect bone.

The Journal of nutrition·1998
Same author

Artifact of I-131 whole-body scan with thoracic vertebral uptake in a patient with papillary thyroid carcinoma.

Clinical nuclear medicine·1997
Same author

Dietary patterns and blood pressure.

The New England journal of medicine·1997
Same author

Anion effects on calcium metabolism.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·1997
Same author

Thyroid disease after the sixth decade.

Current therapy in endocrinology and metabolism·1997

Area of Science:

  • Orthopedics and Bone Health
  • Gerontology
  • Pharmacology

Background:

  • Ongoing refinement of risk factors for bone diseases is crucial.
  • Early detection of bone density loss before fracture is a significant clinical advancement.
  • Understanding bone metabolism is key to developing effective treatments.

Purpose of the Study:

  • To review current and emerging strategies for managing bone density.
  • To highlight advances in early detection and therapeutic interventions.
  • To assess the potential of specific agents in bone health management.

Main Methods:

  • Review of current literature on bone density assessment and risk factors.
  • Analysis of emerging therapeutic strategies for bone loss inhibition and formation.

Related Experiment Videos

  • Evaluation of the efficacy of alendronate and slow-release fluoride.

    • Main Results:

    • Risk factor identification is dynamic, with continuous updates.
    • Bone density assessment enables early detection, preventing fractures.
    • Several strategies effectively inhibit bone loss, with more in development.

    Conclusions:

    • Alendronate and slow-release fluoride show significant promise for bone health.
    • Continued research into bone formation promotion is warranted.
    • Integrated approaches combining risk factor management and early detection are essential.